Product Code: ETC5306071 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The pneumonia vaccine market in Gabon is witnessing growth, driven by increasing awareness about respiratory diseases and the rising need for preventive healthcare. Pneumonia is a leading cause of illness and death in Gabon, particularly among children and the elderly. As the government and healthcare providers focus on improving public health, the demand for pneumonia vaccines is growing. Efforts to expand immunization programs, supported by international health organizations and government initiatives, are playing a critical role in the growth of the market. Additionally, the ongoing focus on strengthening healthcare infrastructure further promotes the widespread availability and adoption of pneumonia vaccines.
The pneumonia vaccine market in Gabon is expanding due to the increasing awareness about the importance of vaccination in preventing respiratory diseases, particularly in young children, the elderly, and people with weakened immune systems. Pneumonia is a leading cause of death, and the rising burden of respiratory diseases in Gabon is driving the demand for vaccines. Government health initiatives and the growing focus on healthcare infrastructure are also supporting the widespread adoption of pneumonia vaccines, contributing to the market`s growth.
The pneumonia vaccine market in Gabon struggles with accessibility and affordability issues. Limited cold chain infrastructure and low public awareness about vaccination programs further complicate the situation.
The pneumonia vaccine market in Gabon is influenced by government policies focused on improving public health and expanding access to vaccines. With a rising focus on preventing infectious diseases, the government is increasing efforts to vaccinate the population against pneumonia and other preventable illnesses. The market benefits from both domestic vaccination programs and international partnerships that aim to reduce healthcare costs and improve public health outcomes in Gabon.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gabon Pneumonia Vaccine Market Overview |
3.1 Gabon Country Macro Economic Indicators |
3.2 Gabon Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Gabon Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Gabon Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Gabon Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Gabon Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Gabon Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Gabon Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Gabon Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Gabon Pneumonia Vaccine Market Trends |
6 Gabon Pneumonia Vaccine Market Segmentations |
6.1 Gabon Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Gabon Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.3 Gabon Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Gabon Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Gabon Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Gabon Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Gabon Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Gabon Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Gabon Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Gabon Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Gabon Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Gabon Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Gabon Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Gabon Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Gabon Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Gabon Pneumonia Vaccine Market Export to Major Countries |
7.2 Gabon Pneumonia Vaccine Market Imports from Major Countries |
8 Gabon Pneumonia Vaccine Market Key Performance Indicators |
9 Gabon Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Gabon Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Gabon Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Gabon Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Gabon Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Gabon Pneumonia Vaccine Market - Competitive Landscape |
10.1 Gabon Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Gabon Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |